[Inhaled glucocorticosteroids in the treatment of asthma and chronic obstructive pulmonary disease].
Molecular mechanisms of actions, pharmacokinetics and anti-inflammatory potency of inhaled glucocorticosteroids (ICS) are described. Differences in clinical effectiveness of ICS in asthma and chronic obstructive pulmonary disease (COPD) therapy and up-to-date recommendations for treatment with ICS in asthma and COPD patients are discussed. Finally there are presented data on safety of long-term treatment with ICS, specially in asthmatic children.
Obojski
Andrzej
A
Klinika Chorób Wewnetrznych i Alergologii AM we Wrocławiu.
Dobek
Rafał
R
Panaszek
Bernard
B
D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D005938:Glucocorticoids